Q4
AARTI DRUGS LTD.
Revenue+19.7%
Net Profit+36.3%
OPM13.30%
P&L
Quarterly Consolidated
Revenue
+19.7%720.30
Expenditure
+13.4%650.70
Net Profit
+36.3%55.26
NPM 7.66%+13.8%EPS ₹6.05+36.3%
vs Q3 FY26
Aarti Drugs Ltd: Financial Results for Year Ended March 31, 2026
15 May 2026 · 15 May, 6:41 pm
Summary
Aarti Drugs Limited reported financial updates for Q4 & FY26.
Informational and educational content only. Not investment advice.